Literature DB >> 22076569

Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus.

Daniel Castillo1, Sonia Puig, Mar Iglesias, Agustín Seoane, Carme de Bolós, Vicente Munitiz, Pascual Parrilla, Laura Comerma, Richard Poulsom, Kausilia K Krishnadath, Luís Grande, Manuel Pera.   

Abstract

BACKGROUND: A human model of gastroesophageal reflux disease was used to examine the contribution of a non-specialized columnar type of metaplasia (NSCM) and key molecular events (BMP4 and CDX2) in the development of Barrett's esophagus.
METHODS: Biopsies of the remnant esophagus from 18 patients undergoing esophagectomy with gastric preservation were taken at 6-36-month intervals postoperatively and examined for activation of the BMP pathway (BMP4/P-Smad 1/5/8) and CDX2 and CDX1 expression by imunohistochemistry, quantitative real-time PCR, Western blot, and in situ hybridization.
RESULTS: A short segment (mean 15.6 mm) of NSCM was detected in 10 (56%) patients, with an increasing prevalence from 17% at 6 months to 62% at 36 months. Nuclear expression of P-Smad 1/5/8 in the squamous epithelium close to the anastomosis with strong expression in all epithelial cells of NSCM areas was found. Forty-eight (63%) biopsies with NSCM showed scattered nuclear expression of CDX2. Two cases showed isolated glands at 18, 24, and 36 months that fully expressed CDX2 and co-expressed CDX1. BMP4 mRNA and CDX2 mRNA levels were significantly greater in NSCM than in squamous epithelium.
CONCLUSIONS: BMP4 activation in NSCM and early expression of CDX2 are involved in the columnar epithelial differentiation of Barrett's esophagus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076569     DOI: 10.1007/s11605-011-1758-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  39 in total

1.  Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.

Authors:  D Vallböhmer; S R DeMeester; J H Peters; D S Oh; H Kuramochi; D Shimizu; J A Hagen; K D Danenberg; P V Danenberg; T R DeMeester; P T Chandrasoma
Journal:  Dis Esophagus       Date:  2006       Impact factor: 3.429

2.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

3.  MiR-9 downregulates CDX2 expression in gastric cancer cells.

Authors:  Pichayanoot Rotkrua; Yoshimitsu Akiyama; Yutaka Hashimoto; Takeshi Otsubo; Yasuhito Yuasa
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

4.  Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells.

Authors:  Tong Liu; Xinyan Zhang; Chi-Kwong So; Su Wang; Peng Wang; Liying Yan; Rene Myers; Zhigang Chen; Amy P Patterson; Chung S Yang; Xiaoxin Chen
Journal:  Carcinogenesis       Date:  2006-09-21       Impact factor: 4.944

5.  Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.

Authors:  Francesca Milano; Jantine W P M van Baal; Navtej S Buttar; Agnieszka M Rygiel; Floor de Kort; Cathrine J DeMars; Wilda D Rosmolen; Jacques J G H M Bergman; Jan VAn Marle; Kenneth K Wang; Maikel P Peppelenbosch; Kausilia K Krishnadath
Journal:  Gastroenterology       Date:  2007-03-19       Impact factor: 22.682

Review 6.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

7.  Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.

Authors:  Roy W Phillips; Henry F Frierson; Christopher A Moskaluk
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

8.  Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.

Authors:  Akashi Eda; Hiroyuki Osawa; Kiichi Satoh; Ichiro Yanaka; Ken Kihira; Yumiko Ishino; Hiroyuki Mutoh; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

9.  Cytokeratin and CDX-2 expression in Barrett's esophagus.

Authors:  Jantine W P M van Baal; Andreas Bozikas; Rick Pronk; Fibo J W Ten Kate; Francesca Milano; Agnieszka M Rygiel; Wilda D Rosmolen; Maikel P Peppelenbosch; Jacques J G H M Bergman; Kausilia K Krishnadath
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

10.  Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines.

Authors:  Patrícia Mesquita; Nicolas Jonckheere; Raquel Almeida; Marie-Paule Ducourouble; Jacinta Serpa; Elisabete Silva; Pascal Pigny; Filipe Santos Silva; Celso Reis; Debra Silberg; Isabelle Van Seuningen; Leonor David
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

View more
  16 in total

Review 1.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

Review 2.  Barrett oesophagus: lessons on its origins from the lesion itself.

Authors:  Stuart A C McDonald; Danielle Lavery; Nicholas A Wright; Marnix Jansen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-11-04       Impact factor: 46.802

3.  Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up.

Authors:  Xuefeng Zhang; Maria Westerhoff; John Hart
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

Review 4.  Review on novel concepts of columnar lined esophagus.

Authors:  Johannes Lenglinger; Stephanie Fischer See; Lukas Beller; Enrico P Cosentini; Reza Asari; Fritz Wrba; Martin Riegler; Sebastian F Schoppmann
Journal:  Wien Klin Wochenschr       Date:  2013-09-06       Impact factor: 1.704

5.  Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.

Authors:  Claire Palles; Laura Chegwidden; Xinzhong Li; John M Findlay; Garry Farnham; Francesc Castro Giner; Maikel P Peppelenbosch; Michal Kovac; Claire L Adams; Hans Prenen; Sarah Briggs; Rebecca Harrison; Scott Sanders; David MacDonald; Chris Haigh; Art Tucker; Sharon Love; Manoj Nanji; John deCaestecker; David Ferry; Barrie Rathbone; Julie Hapeshi; Hugh Barr; Paul Moayyedi; Peter Watson; Barbara Zietek; Neera Maroo; Laura Gay; Tim Underwood; Lisa Boulter; Hugh McMurtry; David Monk; Praful Patel; Krish Ragunath; David Al Dulaimi; Iain Murray; Konrad Koss; Andrew Veitch; Nigel Trudgill; Chuka Nwokolo; Bjorn Rembacken; Paul Atherfold; Elaine Green; Yeng Ang; Ernst J Kuipers; Wu Chow; Stuart Paterson; Sudarshan Kadri; Ian Beales; Charles Grimley; Paul Mullins; Conrad Beckett; Mark Farrant; Andrew Dixon; Sean Kelly; Matthew Johnson; Shahjehan Wajed; Anjan Dhar; Elinor Sawyer; Rebecca Roylance; Lynn Onstad; Marilie D Gammon; Douglas A Corley; Nicholas J Shaheen; Nigel C Bird; Laura J Hardie; Brian J Reid; Weimin Ye; Geoffrey Liu; Yvonne Romero; Leslie Bernstein; Anna H Wu; Alan G Casson; Rebecca Fitzgerald; David C Whiteman; Harvey A Risch; David M Levine; Tom L Vaughan; Auke P Verhaar; Jan van den Brande; Eelke L Toxopeus; Manon C Spaander; Bas P L Wijnhoven; Luc J W van der Laan; Kausilia Krishnadath; Cisca Wijmenga; Gosia Trynka; Ross McManus; John V Reynolds; Jacintha O'Sullivan; Padraic MacMathuna; Sarah A McGarrigle; Dermot Kelleher; Severine Vermeire; Isabelle Cleynen; Raf Bisschops; Ian Tomlinson; Janusz Jankowski
Journal:  Gastroenterology       Date:  2014-11-05       Impact factor: 22.682

Review 6.  Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction.

Authors:  Nicholas J Clemons; Wayne A Phillips; Reginald V Lord
Journal:  Cancer Biol Ther       Date:  2013-06-17       Impact factor: 4.742

7.  Shigella dysenteriae modulates BMP pathway to induce mucin gene expression in vivo and in vitro.

Authors:  Ashidha Gopal; Soumya Chidambaram Iyer; Udhayakumar Gopal; Niranjali Devaraj; Devaraj Halagowder
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

8.  Bone Morphogenetic Protein (BMP) signaling in development and human diseases.

Authors:  Richard N Wang; Jordan Green; Zhongliang Wang; Youlin Deng; Min Qiao; Michael Peabody; Qian Zhang; Jixing Ye; Zhengjian Yan; Sahitya Denduluri; Olumuyiwa Idowu; Melissa Li; Christine Shen; Alan Hu; Rex C Haydon; Richard Kang; James Mok; Michael J Lee; Hue L Luu; Lewis L Shi
Journal:  Genes Dis       Date:  2014-09

9.  BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.

Authors:  Christine Kestens; Peter D Siersema; G Johan A Offerhaus; Jantine W P M van Baal
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

10.  Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma.

Authors:  Chase Taylor; Holli A Loomans; Gregoire F Le Bras; Rainelli B Koumangoye; Alejandra I Romero-Morales; Laura L Quast; Alexander I Zaika; Wael El-Rifai; Thomas Andl; Claudia D Andl
Journal:  Oncotarget       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.